Cargando…
Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661643/ https://www.ncbi.nlm.nih.gov/pubmed/29263931 http://dx.doi.org/10.1038/sigtrans.2017.54 |
| _version_ | 1783274522187661312 |
|---|---|
| author | Zhang, Wen-ying Liu, Yang Wang, Yao Wang, Chun-meng Yang, Qing-ming Zhu, Hong-li Han, Wei-dong |
| author_facet | Zhang, Wen-ying Liu, Yang Wang, Yao Wang, Chun-meng Yang, Qing-ming Zhu, Hong-li Han, Wei-dong |
| author_sort | Zhang, Wen-ying |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5661643 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-56616432017-12-20 Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials Zhang, Wen-ying Liu, Yang Wang, Yao Wang, Chun-meng Yang, Qing-ming Zhu, Hong-li Han, Wei-dong Signal Transduct Target Ther Correspondence Nature Publishing Group 2017-10-09 /pmc/articles/PMC5661643/ /pubmed/29263931 http://dx.doi.org/10.1038/sigtrans.2017.54 Text en Copyright © 2017 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Correspondence Zhang, Wen-ying Liu, Yang Wang, Yao Wang, Chun-meng Yang, Qing-ming Zhu, Hong-li Han, Wei-dong Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials |
| title | Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials |
| title_full | Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials |
| title_fullStr | Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials |
| title_full_unstemmed | Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials |
| title_short | Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials |
| title_sort | long-term safety and efficacy of cart-20 cells in patients with refractory or relapsed b-cell non-hodgkin lymphoma: 5-years follow-up results of the phase i and iia trials |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661643/ https://www.ncbi.nlm.nih.gov/pubmed/29263931 http://dx.doi.org/10.1038/sigtrans.2017.54 |
| work_keys_str_mv | AT zhangwenying longtermsafetyandefficacyofcart20cellsinpatientswithrefractoryorrelapsedbcellnonhodgkinlymphoma5yearsfollowupresultsofthephaseiandiiatrials AT liuyang longtermsafetyandefficacyofcart20cellsinpatientswithrefractoryorrelapsedbcellnonhodgkinlymphoma5yearsfollowupresultsofthephaseiandiiatrials AT wangyao longtermsafetyandefficacyofcart20cellsinpatientswithrefractoryorrelapsedbcellnonhodgkinlymphoma5yearsfollowupresultsofthephaseiandiiatrials AT wangchunmeng longtermsafetyandefficacyofcart20cellsinpatientswithrefractoryorrelapsedbcellnonhodgkinlymphoma5yearsfollowupresultsofthephaseiandiiatrials AT yangqingming longtermsafetyandefficacyofcart20cellsinpatientswithrefractoryorrelapsedbcellnonhodgkinlymphoma5yearsfollowupresultsofthephaseiandiiatrials AT zhuhongli longtermsafetyandefficacyofcart20cellsinpatientswithrefractoryorrelapsedbcellnonhodgkinlymphoma5yearsfollowupresultsofthephaseiandiiatrials AT hanweidong longtermsafetyandefficacyofcart20cellsinpatientswithrefractoryorrelapsedbcellnonhodgkinlymphoma5yearsfollowupresultsofthephaseiandiiatrials |